Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$35.75 USD
-0.41 (-1.13%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $35.74 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
COLL 35.75 -0.41(-1.13%)
Will COLL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for COLL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COLL
Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key Metrics
Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates
COLL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inotiv, Inc. (NOTV) Reports Q3 Loss, Tops Revenue Estimates
Zevra Therapeutics (ZVRA) Reports Next Week: Wall Street Expects Earnings Growth
Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards?
Other News for COLL
Is COLL ready to move higher? 50 Day Moving Average Support shows up after climbing 1.74%
Lower Bollinger Band Walk appears for COLL after 0.22% move
Is COLL poised for gains? Crossed Above 50 Day Moving Average shows up after advancing 2.0%
COLL Fell Below 50 Day Moving Average on September 15
COLL Fell Below 20 Day Moving Average on September 12